Q2 2016 13F Holders as of 30 Jun 2016
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
86.6M
-
Number of holders
-
46
-
Total 13F shares, excl. options
-
10.3M
-
Shares change
-
+1.11M
-
Total reported value, excl. options
-
$101M
-
Value change
-
+$10.8M
-
Number of buys
-
29
-
Number of sells
-
-10
-
Price
-
$9.85
Significant Holders of Syndax Pharmaceuticals Inc - Common Stock, par value $0.0001 per share (SNDX) as of Q2 2016
47 filings reported holding SNDX - Syndax Pharmaceuticals Inc - Common Stock, par value $0.0001 per share as of Q2 2016.
Syndax Pharmaceuticals Inc - Common Stock, par value $0.0001 per share (SNDX) has 46 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 10.3M shares
of 86.6M outstanding shares and own 11.86% of the company stock.
Largest 10 shareholders include MPM ASSET MANAGEMENT LLC (2.17M shares), FMR LLC (2.09M shares), WELLINGTON MANAGEMENT GROUP LLP (1.29M shares), BlackRock Advisors LLC (1.03M shares), ORBIMED ADVISORS LLC (757K shares), JENNISON ASSOCIATES LLC (538K shares), EcoR1 Capital, LLC (357K shares), Redmile Group, LLC (251K shares), Boxer Capital, LLC (234K shares), and Cormorant Asset Management, LLC (214K shares).
This table shows the top 46 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.